20,622
XNAS Volume
XNAS
23 Apr, 2025 5:30 PM (EDT)
Tvardi Therapeutics Inc. - TVRD - stock price prediction, stock price target, analyst ratings from 2 analysts
Tvardi Therapeutics Inc. has a share price target of US$ 1, revenue growth forecast of -25.0%, for FY25, based on top 2 analyst calls.